Diluted EPS came in at $-139.86, missed the $-0.07 consensus by $139.79.
Trailing eight quarters through Q2 2024
Common questions about ENDRA Life Sciences Inc.'s Q2 2024 earnings report.
ENDRA Life Sciences Inc. (NDRA) reported Q2 2024 earnings on August 14, 2024 after market close.
ENDRA Life Sciences Inc. reported diluted EPS of $-139.86 for Q2 2024.
EPS missed the consensus estimate of $-0.07 by $139.79.
You can read the 10-Q periodic report (0001654954-24-010642) directly on SEC EDGAR. The filing index links above go to sec.gov.